Pharmacokinetics

Pharmacokinetics may at first sound intimidating, but let’s bring it back down to Earth. Picture it as a fascinating journey of a medication inside our body, similar to the dramatic arc of a novel with four main stages: absorption, distribution, metabolism, and excretion. Let’s call these stages ADME for short, the ABCs of pharmacokinetics.

1. Absorption: Tickets, Please!

Imagine you’ve just taken a pill for a pesky headache. This pill, let’s call it our protagonist, starts its journey in your body via absorption. Absorption is all about how the drug moves from the outside world into your bloodstream. Think of it as the drug getting its ticket punched for the train ride at the station. Depending on the route of administration, this station could be your stomach, your intestines, or even your skin.

………..The full text is available to members.

Click to become a member

Now, not all drugs hop on the train at the same speed. Some get absorbed rapidly, while others take their time. Many factors can influence this, such as the drug’s formulation, the presence of food in your stomach, and the specific part of the body where the drug is introduced.

2. Distribution: The Grand Tour

Once our drug, now a full-fledged passenger in your bloodstream, it begins its grand tour of your body. This is called distribution. Your bloodstream is like the highway system of your body, carrying the drug to various “cities” or tissues.

Some drugs are attracted to busy, bustling cities like your heart or brain. Others prefer quieter places, like fat tissues. Drugs might also bind with proteins in the blood, essentially hitching a ride. How widely and quickly a drug is distributed depends on factors like blood flow, tissue type, and the drug’s ability to cross barriers like the blood-brain barrier, which acts like a strict bouncer at the entrance to the brain.

3. Metabolism: Makeovers and Modifications

But, just like in any epic tale, our protagonist undergoes some changes. This is metabolism. Primarily taking place in the liver, your body’s sophisticated “mechanic,” metabolism modifies the drug. It’s a bit like the drug going to a stylist for a makeover.

This makeover can make the drug more active (like a prodrug, which only works after metabolism), less active, or even inactive. Sometimes, it’s just about prepping the drug to be excreted, making it more water-soluble so it’s easier to remove. These changed versions of the drug are known as metabolites.

4. Excretion: Time to Say Goodbye

The final chapter in our drug’s journey is excretion. This is the body’s way of escorting the drug to the exit, primarily through the kidneys into the urine. Other ways of saying goodbye are through the lungs, sweat, and feces.

Excretion is crucial because it prevents the drug from overstaying its welcome. Too much of a good thing can be harmful, and that applies to medications too. The rate of excretion can impact how long a drug stays effective and can vary with factors such as age, kidney function, and hydration status.

Conclusion:

Pharmacokinetics, in essence, is the life story of a drug within our bodies. As medical professionals, understanding this story helps us grasp why we administer drugs the way we do, why certain drugs are not suitable for some patients, and why the timing of medication administration matters.

Remember, each drug is unique. They’re like characters in a novel, each with their own backstory and journey. So the more familiar you are with these journeys, the better you’ll be at predicting plot twists and turning them into better patient outcomes.

5. Factors Affecting Pharmacokinetics: The Plot Twists

Our drug’s journey isn’t always straightforward. Certain factors can create plot twists, altering how a drug is absorbed, distributed, metabolized, or excreted. Age is a big one: a drug may have a different adventure in an infant or elderly person compared to a young adult because of differences in organ function and body composition.

Health status also plays a role. Imagine if the highways (blood vessels) are under construction (due to a condition like atherosclerosis). The drug won’t be able to get around as quickly or easily.

Other plot twists might include genetic differences affecting how a person’s body handles a drug, interactions with other medications, and lifestyle factors like diet and exercise. Understanding these variables helps us predict how these stories might unfold differently in different people.

6. Application in Medical Practice: Using the Stories to Our Advantage

Here’s where pharmacokinetics leaps off the page and into your professional practice. Say you have a patient who needs pain relief but has poor kidney function. Knowing that certain pain medications are primarily excreted by the kidneys (our drug’s exit strategy), you’d know to consult with the healthcare team about adjusting the dose or possibly choosing a different medication to avoid potential harm.

Or perhaps you’re caring for a patient who is on a medication that’s metabolized in the liver (our drug’s makeover spot), but they also have liver disease. This knowledge alerts you to the need for careful monitoring for side effects or signs of toxicity, as the drug might hang around longer than usual.

Conclusion:

At its heart, pharmacokinetics is about stories – the epic adventures of drugs in the body. From their grand entrance (absorption), through their wide-ranging journeys (distribution), their striking transformations (metabolism), to their eventual departure (excretion), it’s a narrative filled with valuable insights.

By understanding these stories and their potential plot twists, you can apply this knowledge to improve patient care, reduce the risk of adverse drug reactions, and enhance therapeutic outcomes. Pharmacokinetics, then, isn’t just an intimidating term; it’s an invaluable tool in your professional toolkit.

Absorption is the first step in the pharmacokinetic process and refers to the passage of a drug from its site of administration into the systemic circulation (bloodstream). It is a crucial step that determines the onset, intensity, and duration of a drug’s action in the body. 

• The rate of absorption determines how soon the drug will take affect. 
• The amount of absorption determines the intensity of the drug’s effect. 

………..The full text is available to members.

Click to become a member

Factors influencing drug absorption include:

1. Drug formulation: The physical and chemical properties of a drug, such as solubility, particle size, and ionization state, can affect its absorption.

2. Route of administration: The route through which a drug is administered (e.g., oral, intravenous, intramuscular, subcutaneous, transdermal) can impact its absorption rate and bioavailability. See below for more information.

3. Physiological factors: Patient-specific factors, such as gastrointestinal motility, pH, and blood flow, can influence drug absorption.

 

Routes of Administration In pharmacology, the route of administration refers to  the method used to introduce a drug into the body. The choice of administration route depends on factors such as the drug’s physicochemical properties, its intended effect, the desired onset and duration of action, and the patient’s age and medical condition. There are several routes of administration, which can be broadly classified into two categories: enteral and parenteral. Enteral routes: Enteral administration involves introducing a drug into the gastrointestinal (GI) tract. This category includes the following routes: Oral: Drugs are swallowed and absorbed through the GI tract. This is the most common and convenient route, but it may have limitations due to the first-pass metabolism in the liver and possible degradation in the stomach. Sublingual: The drug is placed under the tongue and is absorbed through the mucous membrane. This route bypasses the first-pass metabolism and provides rapid onset of action.  Buccal: The drug is placed between the cheek and gum and is absorbed through the buccal mucosa. This route also avoids first-pass metabolism. Rectal: Drugs are administered through the rectum using suppositories or enemas. This route can be helpful for patients with nausea or vomiting, and it partially avoids first-pass metabolism. Parenteral routes:Parenteral administration involves introducing a drug into the body via routes other than the GI tract. This category includes the following routes: Intravenous (IV): The drug is injected directly into a vein, resulting in immediate onset of action and 100% bioavailability. This route is suitable for drugs that are poorly absorbed orally or for situations that require rapid drug delivery. Intramuscular (IM): The drug is injected into a muscle, where it is absorbed into the bloodstream. This route allows for a slower, sustained release of the drug and is suitable for drugs that require a prolonged effect. Subcutaneous (SC or SQ): The drug is injected into the fatty tissue just beneath the skin, allowing for slow absorption into the bloodstream. This route is used for drugs that require a slower, sustained release. Intradermal (ID): The drug is injected into the dermis, the layer of skin just below the epidermis. This route is often used for diagnostic tests and vaccines. Inhalation: The drug is inhaled into the lungs, either as a gas, aerosol, or fine powder, and absorbed through the respiratory system. This route is useful for drugs that target the respiratory system or need rapid systemic absorption. Transdermal: The drug is applied to the skin, usually in the form of a patch, and is absorbed slowly through the skin layers. This route allows for controlled, sustained release and is suitable for drugs that require a steady blood concentration over time. Intranasal: The drug is administered through the nose, either as a spray or powder, and is absorbed through the nasal mucosa. This route is useful for drugs that need rapid absorption and direct access to the central nervous system. Intraocular: The drug is introduced directly into the eye, either as eye drops or through injection. This route is used for drugs that target eye-related conditions. Intrathecal: The drug is injected directly into the cerebrospinal fluid surrounding the spinal cord. This route is used for drugs that need to bypass the blood-brain barrier to treat central nervous system disorders.

Distribution is the second step in the pharmacokinetic process, referring to the transport of a drug from the bloodstream to various tissues and organs throughout the body. Once a drug is absorbed into the systemic circulation, it can either remain in the bloodstream or distribute to the target and non-target tissues. The extent and rate of distribution are crucial in determining the drug’s therapeutic effects and potential side effects. Several factors can influence drug distribution:

………..The full text is available to members.

Click to become a member

1. Blood flow to tissues: The rate at which a drug reaches its target site depends on the blood flow to the specific tissue or organ. Organs with high blood flow, such as the liver, kidneys, and brain, receive drugs more rapidly, while those with lower blood flow, like adipose (fat) tissue, receive drugs more slowly.
2. Plasma protein binding: Many drugs bind to plasma proteins, primarily albumin, in the bloodstream. Only the unbound (free) portion of the drug can distribute to tissues and exert its pharmacological effects. The extent of plasma protein binding can affect the distribution of a drug, as drugs with a high degree of protein binding have a limited ability to distribute into tissues. Very important concept! See more information below.

    

3. Tissue permeability: The ability of a drug to cross biological membranes and enter cells or tissues depends on its physicochemical properties, such as lipophilicity (fat solubility) and molecular size. Lipophilic drugs can readily cross cell membranes, while hydrophilic (water-soluble) drugs have limited permeability.
4. Tissue-specific factors: Certain tissues may have a higher affinity for specific drugs due to the presence of receptors or other binding sites. For example, some drugs have a high affinity for adipose tissue, which can serve as a reservoir for lipophilic drugs, prolonging their action and affecting their distribution.

Metabolism is the third step in the pharmacokinetic process, which involves the biotransformation of a drug into different chemical compounds, known as metabolites. The primary goal of drug metabolism is to convert lipophilic (fat-soluble) drugs into more polar (water-soluble) metabolites, making them easier to excrete from the body. Metabolism can also result in the activation or inactivation of a drug, impacting its therapeutic effects and potential side effects. The liver is the primary organ responsible for drug metabolism, although other tissues, such as the gastrointestinal tract, kidneys, and lungs, may also contribute.

………..The full text is available to members.

Click to become a member

[/s2If] [s2If current_user_can(access_s2member_level1)]

Drug metabolism in the liver is primarily mediated by enzymes, with the most significant enzyme family involved in this process being the cytochrome P450 (CYP450) enzymes. 

There are more than 50 human CYP450 enzymes, which are divided into families and subfamilies based on their amino acid sequence similarities. The most clinically significant CYP450 families involved in drug metabolism are CYP1, CYP2, and CYP3. 

Inhibition and Induction

In the context of drug metabolism, inhibition and induction refer to the processes by which a drug or other substance affects the activity of drug-metabolizing enzymes, particularly the cytochrome P450 (CYP450) enzymes. Both inhibition and induction can have significant clinical implications, as they can influence the rate at which a drug is metabolized, potentially leading to altered drug efficacy, side effects, and drug interactions.

1. Inhibition: Inhibition occurs when a drug or other substance decreases the activity of a drug-metabolizing enzyme. This can result in a reduced rate of drug metabolism, leading to increased plasma concentrations of the affected drug. As a consequence, the risk of side effects or toxicity may increase. 
2. Induction: Induction refers to the process by which a drug or other substance increases the activity or expression of drug-metabolizing enzymes. Induction can lead to increased drug metabolism, resulting in reduced plasma concentrations of the affected drug, which may decrease its efficacy.

Some factors that can influence drug metabolism include:

1. Genetic variations: Individual genetic differences in the expression or function of drug-metabolizing enzymes can impact the rate and extent of drug metabolism, leading to variations in drug response and susceptibility to side effects.

2. Liver function: The liver’s metabolic capacity can be affected by factors such as age, disease, and nutritional status, which can alter drug metabolism and influence drug response.

3. Drug-drug interactions: The concomitant administration of multiple drugs can lead to interactions that affect drug metabolism, either by inducing or inhibiting the activity of drug-metabolizing enzymes.

4. Environmental factors: Lifestyle factors such as diet, smoking, and alcohol consumption can influence the expression and activity of drug-metabolizing enzymes.

Excretion is the fourth and final step in the pharmacokinetic process, which involves the elimination of drugs and their metabolites from the body. The primary goal of excretion is to remove these substances to prevent their accumulation and maintain a balance within the body. Efficient excretion is essential for terminating a drug’s action and preventing potential toxicity. There are several routes and mechanisms of excretion, with the kidneys and liver being the most important organs involved.

………..The full text is available to members.

Click to become a member

[/s2If] [s2If current_user_can(access_s2member_level1)]

1. Renal excretion: The kidneys play a central role in the elimination of drugs and their metabolites, primarily through a process called glomerular filtration. In this process, blood is filtered through the glomerulus, a network of capillaries in the kidneys, and the filtrate containing water, electrolytes, and small molecules, including drugs and their metabolites, is collected in the renal tubules. Some substances in the filtrate are reabsorbed back into the bloodstream, while others are actively secreted into the tubules. The final filtrate, containing the drug and its metabolites, is excreted as urine.

    

2. Hepatic excretion: The liver is another essential organ involved in drug excretion, primarily through the process of biliary excretion. In this process, drugs and their metabolites are secreted into bile, which is then transported to the small intestine and eliminated from the body through feces. Some drugs and metabolites can be reabsorbed from the intestine back into the bloodstream, a process known as enterohepatic recirculation, which can prolong the drug’s action and affect its excretion.

3. Other routes of excretion include:

   1. Pulmonary excretion: Some volatile drugs, such as anesthetic gases, can be eliminated through exhalation from the lungs.

   2. Sweat, saliva, and tears: Small amounts of drugs and their metabolites can be excreted in sweat, saliva, and tears, although these routes are generally not significant for most drugs.

   3. Breast milk: Some drugs can be excreted in breast milk, posing a risk to nursing infants.

Steps to Renal Drug Excretion

1. Glomerular filtration: The first step in renal excretion is the filtration of blood in the glomerulus, which is a network of tiny blood vessels (capillaries) within the kidney. Blood flows into the glomerulus, where hydrostatic pressure forces water, electrolytes, small molecules (including drugs), and waste products across the glomerular filtration barrier into the Bowman’s capsule. This filtrate, now called the glomerular filtrate, is essentially free of large molecules, such as proteins and blood cells.

2. Tubular secretion: After glomerular filtration, the filtrate enters the renal tubules. In this step, the tubular cells secrete certain substances, including drugs and their metabolites, from the blood into the tubular fluid. This process is particularly important for drugs that are not easily filtered through the glomerulus due to their size, charge, or protein binding. Active transport mechanisms, such as organic anion and cation transporters, are involved in tubular secretion, and they help move substances against their concentration gradients.

3. Tubular reabsorption: As the tubular fluid moves along the renal tubules (from the proximal tubule to the distal tubule and collecting duct), various substances, including water, electrolytes, and some drugs, are reabsorbed back into the bloodstream. The extent of reabsorption depends on the drug’s physicochemical properties, such as its lipophilicity (ability to dissolve in fat), ionization state, and molecular size. Reabsorption can occur through passive diffusion, facilitated diffusion, or active transport. 

   1. Lipophilic (fat-soluble) drugs can easily cross cell membranes, including those lining the renal tubules. As the tubular fluid moves along the nephron, lipophilic drugs may passively diffuse back into the bloodstream due to their ability to dissolve in the lipid bilayers of the tubular cells. 
      • It is for this reason that the liver strives to metabolize lipophilic drugs into a more polar form (hydrophilic), to aid in excretion of drugs from the body.